Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Tempest Therapeutics Total Assets 2012-2025 | TPST

Tempest Therapeutics total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Tempest Therapeutics Annual Total Assets
(Millions of US $)
2024 $41
2023 $52
2022 $46
2021 $73
2020 $23
2019 $75
2018 $84
2017 $20
2016 $123
2015 $139
2014 $66
2013 $48
2012 $33
2011 $5
Tempest Therapeutics Quarterly Total Assets
(Millions of US $)
2025-06-30 $24
2025-03-31 $32
2024-12-31 $41
2024-09-30 $34
2024-06-30 $42
2024-03-31 $44
2023-12-31 $52
2023-09-30 $24
2023-06-30 $31
2023-03-31 $37
2022-12-31 $46
2022-09-30 $63
2022-06-30 $71
2022-03-31 $67
2021-12-31 $73
2021-09-30 $67
2021-06-30 $75
2021-03-31 $32
2020-12-31 $23
2020-09-30 $49
2020-06-30 $57
2020-03-31 $68
2019-12-31 $75
2019-09-30 $58
2019-06-30 $68
2019-03-31 $74
2018-12-31 $84
2018-09-30 $49
2018-06-30 $56
2018-03-31 $63
2017-12-31 $20
2017-09-30 $82
2017-06-30 $94
2017-03-31 $106
2016-12-31 $123
2016-09-30 $142
2016-06-30 $159
2016-03-31 $122
2015-12-31 $139
2015-09-30 $153
2015-06-30 $164
2015-03-31 $176
2014-12-31 $66
2014-09-30 $77
2014-06-30 $86
2014-03-31 $93
2013-12-31 $48
2013-09-30 $51
2013-06-30 $56
2013-03-31 $61
2012-12-31 $33
2012-09-30 $36
2012-06-30 $35
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.042B $0.000B
Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $71.679B 27.57
Zoetis (ZTS) United States $69.473B 25.20
Daiichi Sankyo, - (DSNKY) Japan $49.821B 25.53
Takeda Pharmaceutical (TAK) Japan $49.256B 10.05
BeOne Medicines - (ONC) Switzerland $33.903B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.730B 0.00
Summit Therapeutics (SMMT) United States $19.217B 0.00
Merck (MKKGY) Germany $16.847B 10.95
Shionogi (SGIOY) Japan $15.243B 15.27
United Therapeutics (UTHR) United States $13.824B 11.96
Neurocrine Biosciences (NBIX) United States $13.214B 39.42
Orion OYJ (ORINY) Finland $11.248B 27.11
IPSEN (IPSEY) France $11.218B 0.00
Eisai (ESAIY) $9.333B 10.53
Madrigal Pharmaceuticals (MDGL) United States $8.696B 0.00
Corcept Therapeutics (CORT) United States $7.418B 62.30
Grifols, S.A (GRFS) Spain $6.979B 0.00
Stevanato Group S.p.A (STVN) Italy $6.935B 40.89
Ionis Pharmaceuticals (IONS) United States $6.824B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.355B 18.39
Soleno Therapeutics (SLNO) United States $3.664B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.955B 14.05
Crinetics Pharmaceuticals (CRNX) United States $2.740B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.739B 0.00
Hypermarcas (HYPMY) Brazil $2.689B 20.21
Catalyst Pharmaceuticals (CPRX) United States $2.489B 8.34
Centessa Pharmaceuticals (CNTA) United Kingdom $2.314B 0.00
Ocular Therapeutix (OCUL) United States $2.081B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.703B 0.00
Guardian Pharmacy Services (GRDN) United States $1.649B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.581B 23.55
Ardelyx (ARDX) United States $1.443B 0.00
ARS Pharmaceuticals (SPRY) United States $1.443B 0.00
Harrow (HROW) United States $1.415B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.384B 0.00
Evotec AG (EVO) Germany $1.268B 0.00
Xeris Biopharma Holdings (XERS) United States $1.222B 0.00
Collegium Pharmaceutical (COLL) United States $1.209B 6.60
Enliven Therapeutics (ELVN) United States $1.165B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Akebia Therapeutics (AKBA) United States $0.827B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.742B 7.65
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
Theravance Biopharma (TBPH) United States $0.674B 55.79
ProKidney (PROK) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.645B 0.00
Siga Technologies (SIGA) United States $0.629B 7.77
Elite Pharmaceuticals (ELTP) United States $0.603B 0.00
Bioventus (BVS) United States $0.596B 14.42
Relay Therapeutics (RLAY) United States $0.586B 0.00
Organogenesis (ORGO) United States $0.581B 0.00
Tourmaline Bio (TRML) United States $0.577B 0.00
USANA Health Sciences (USNA) United States $0.569B 11.65
Oruka Therapeutics (ORKA) United States $0.539B 0.00
Xencor (XNCR) United States $0.536B 0.00
Savara (SVRA) United States $0.534B 0.00
Zevra Therapeutics (ZVRA) United States $0.521B 0.00
Nektar Therapeutics (NKTR) United States $0.513B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Nanobiotix S.A (NBTX) France $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.387B 0.00
Aldeyra Therapeutics (ALDX) United States $0.337B 0.00
Altimmune (ALT) United States $0.320B 0.00
4D Molecular Therapeutics (FDMT) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.316B 0.00
Larimar Therapeutics (LRMR) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.95
AleAnna (ANNA) United States $0.274B 0.00
Galectin Therapeutics (GALT) United States $0.250B 0.00
OmniAb (OABI) United States $0.225B 0.00
Lyell Immunopharma (LYEL) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.199B 0.00
Aclaris Therapeutics (ACRS) United States $0.196B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.185B 0.00
Korro Bio (KRRO) United States $0.181B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.178B 27.50
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.125B 0.00
Avita Medical (RCEL) United States $0.125B 0.00
Avalo Therapeutics (AVTX) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.101B 22.88
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.097B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Liminatus Pharma (LIMN) United States $0.087B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.083B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Prelude Therapeutics (PRLD) United States $0.059B 0.00
DURECT (DRRX) United States $0.059B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Inotiv (NOTV) United States $0.057B 0.00
Karyopharm Therapeutics (KPTI) United States $0.056B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.55
Century Therapeutics (IPSC) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
FibroGen (FGEN) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.01
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.57
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.55
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00